News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Annie Guérin

Articles by Annie Guérin

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Giredestrant Exhibits DFS Improvement in Early-Stage Breast Cancer

FDA Approves Epcoritamab Combo in R/R Follicular Lymphoma

Real-World Niraparib Efficacy Similar to Phase 3 Data in Ovarian Cancer

How Does NALIRIFOX Fit Into the Metastatic PDAC Treatment Paradigm?

NALIRIFOX Shows Survival Benefit Vs Gemcitabine/Nab-Paclitaxel in Metastatic PDAC

© 2025 MJH Life Sciences^®

All rights reserved.